Elevian is developing new medicines that promote recovery and regeneration, specifically targeting the treatment of stroke and aging-related diseases using a recombinant protein called rGDF11.
competitor of
Metrics
marketPRIVATE
msh_idCOM:ELEVIAN
localeus
websitehttps://www.elevian.com/
source_ref9c1a7812-8946-45b8-b2b6-504137cb73a1
products_or_servicesDevelopment of a recombinant protein for the treatment of stroke and various aging-associated diseases.